{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T18:37:26Z","timestamp":1720550246992},"reference-count":76,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Med Report"],"DOI":"10.3892\/mmr.2018.9672","type":"journal-article","created":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T07:59:31Z","timestamp":1542700771000},"source":"Crossref","is-referenced-by-count":1,"title":["Establishment of microRNA, transcript and protein regulatory networks in Alport syndrome induced pluripotent stem cells"],"prefix":"10.3892","author":[{"given":"Wenbiao","family":"Chen","sequence":"first","affiliation":[{"name":"State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donge","family":"Tang","sequence":"additional","affiliation":[{"name":"Clinical Medical Research Center, The Second Clinical Medical College of Jinan University (Shenzhen People's Hospital), Shenzhen, Guangdong 518020, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Dai","sequence":"additional","affiliation":[{"name":"Clinical Medical Research Center, The Second Clinical Medical College of Jinan University (Shenzhen People's Hospital), Shenzhen, Guangdong 518020, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyan","family":"Diao","sequence":"additional","affiliation":[{"name":"State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2018,11,20]]},"reference":[{"key":"key20200713231432_b1-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1681\/ASN.2008090984","article-title":"The renal lesions of Alport syndrome","volume":"20","author":"Heidet","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"key20200713231432_b2-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/nrneph.2012.259","article-title":"Alport syndrome-insights from basic and clinical research","volume":"9","author":"Kruegel","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"key20200713231432_b3-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.mcp.2010.10.001","article-title":"Collagen type IV nephropathy: Genetic heterogeneity examinations in affected hungarian families","volume":"25","author":"Endreffy","year":"2011","journal-title":"Mol Cell Probes"},{"key":"key20200713231432_b4-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"c82","DOI":"10.1159\/000101802","article-title":"Alport syndrome and thin basement membrane nephropathy","volume":"106","author":"Thorner","year":"2007","journal-title":"Nephron Clin Pract"},{"key":"key20200713231432_b5-mmr-19-01-0238","doi-asserted-by":"crossref","first-page":"224","DOI":"10.5858\/133.2.224","article-title":"Alport syndrome and thin glomerular basement membrane nephropathy: A practical approach to diagnosis","volume":"133","author":"Haas","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"key20200713231432_b6-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1042\/CS20170245","article-title":"Genetic diagnosis of polycystic kidney disease, Alport syndrome, and thalassemia minor in a large Chinese family","volume":"131","author":"Miao","year":"2017","journal-title":"Clin Sci (Lond)"},{"key":"key20200713231432_b7-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s00467-015-3302-4","article-title":"Identification of 47 novel mutations in patients with alport syndrome and thin basement membrane nephropathy","volume":"31","author":"Weber","year":"2016","journal-title":"Pediatr Nephrol"},{"key":"key20200713231432_b8-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.2215\/CJN.04140414","article-title":"X-linked Alport syndrome caused by splicing mutations in COL4A5","volume":"9","author":"Nozu","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"key20200713231432_b9-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1681\/ASN.2013070798","article-title":"Feasibility of repairing glomerular basement membrane defects in alport syndrome","volume":"25","author":"Lin","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"key20200713231432_b10-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"3631","DOI":"10.1007\/s11033-014-3227-1","article-title":"Identification of a novel COL4A5 mutation in a Chinese family with X-linked Alport syndrome using exome sequencing","volume":"41","author":"Guo","year":"2014","journal-title":"Mol Biol Rep"},{"key":"key20200713231432_b11-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.tig.2006.01.003","article-title":"Genomics of microRNA","volume":"22","author":"Kim","year":"2006","journal-title":"Trends Genet"},{"key":"key20200713231432_b12-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.bbrc.2007.08.030","article-title":"miRNomics-the bioinformatics of microRNA genes","volume":"363","author":"Ghosh","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"key20200713231432_b13-mmr-19-01-0238","first-page":"169","article-title":"MicroRNA and nephropathy: Emerging concepts","volume":"6","author":"Chung","year":"2013","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"key20200713231432_b14-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3892\/ijmm.2013.1554","article-title":"Integrated profiling of microRNA expression in membranous nephropathy using high-throughput sequencing technology","volume":"33","author":"Chen","year":"2014","journal-title":"Int J Mol Med"},{"key":"key20200713231432_b15-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1139\/gen-2012-0159","article-title":"Genome-wide analysis of microRNAs expression profiling in patients with primary IgA nephropathy","volume":"56","author":"Tan","year":"2013","journal-title":"Genome"},{"key":"key20200713231432_b16-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1177\/0961203307084158","article-title":"Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients","volume":"16","author":"Dai","year":"2007","journal-title":"Lupus"},{"key":"key20200713231432_b17-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.cell.2010.03.009","article-title":"Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP","volume":"141","author":"Hafner","year":"2010","journal-title":"Cell"},{"key":"key20200713231432_b18-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.2337\/db10-1181","article-title":"Transcriptome analysis of human diabetic kidney disease","volume":"60","author":"Woroniecka","year":"2011","journal-title":"Diabetes"},{"key":"key20200713231432_b19-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1111\/j.1600-6143.2007.01980.x","article-title":"Transcriptome analysis reveals heterogeneity in the injury response of kidney transplants","volume":"7","author":"Famulski","year":"2007","journal-title":"Am J Transplant"},{"key":"key20200713231432_b20-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1517\/17460441.2012.724055","article-title":"Proteomics approaches for myeloid leukemia drug discovery","volume":"7","author":"Kapoor","year":"2012","journal-title":"Expert Opin Drug Discov"},{"key":"key20200713231432_b21-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1039\/c2mb25396h","article-title":"Urinary exosomes and diabetic nephropathy: A proteomic approach","volume":"9","author":"Raimondo","year":"2013","journal-title":"Mol Biosyst"},{"key":"key20200713231432_b22-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/pmic.200500023","article-title":"Establishment of a 2-D human urinary proteomic map in IgA nephropathy","volume":"6","author":"Park","year":"2006","journal-title":"Proteomics"},{"key":"key20200713231432_b23-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1097\/FJC.0b013e318247f642","article-title":"Induced pluripotent stem cells as a disease modeling and drug screening platform","volume":"60","author":"Ebert","year":"2012","journal-title":"J Cardiovasc Pharmacol"},{"key":"key20200713231432_b24-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1146\/annurev-bioeng-071813-105108","article-title":"Induced pluripotent stem cells for regenerative medicine","volume":"16","author":"Hirschi","year":"2014","journal-title":"Annu Rev Biomed Eng"},{"key":"key20200713231432_b25-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1002\/stem.1653","article-title":"A simple and efficient system for regulating gene expression in human pluripotent stem cells and derivatives","volume":"32","author":"Qian","year":"2014","journal-title":"Stem Cells"},{"key":"key20200713231432_b26-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.gde.2017.07.001","article-title":"MicroRNAs and RNA binding protein regulators of microRNAs in the control of pluripotency and reprogramming","volume":"46","author":"Hao","year":"2017","journal-title":"Curr Opin Genet Dev"},{"key":"key20200713231432_b27-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ydbio.2010.05.014","article-title":"Emerging roles of microRNAs in the control of embryonic stem cells and the generation of induced pluripotent stem cells","volume":"344","author":"Mallanna","year":"2010","journal-title":"Dev Biol"},{"key":"key20200713231432_b28-mmr-19-01-0238","first-page":"101","article-title":"Generation of induced pluripotent stem cells from renal tubular cells of a patient with Alport syndrome","volume":"8","author":"Chen","year":"2015","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"key20200713231432_b29-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1101\/gr.7.10.986","article-title":"The significance of digital gene expression profiles","volume":"7","author":"Audic","year":"1997","journal-title":"Genome Res"},{"key":"key20200713231432_b30-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20200713231432_b31-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12964-015-0123-9","article-title":"Motif co-regulation and co-operativity are common mechanisms in transcriptional, post-transcriptional and post-translational regulation","volume":"13","author":"Van Roey","year":"2015","journal-title":"Cell Commun Signal"},{"key":"key20200713231432_b32-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/fcell.2015.00002","article-title":"Induced pluripotent stem cells: Applications in regenerative medicine, disease modeling, and drug discovery","volume":"3","author":"Singh","year":"2015","journal-title":"Front Cell Dev Biol"},{"key":"key20200713231432_b33-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/jdi.12702","article-title":"iPSC technology-based regenerative therapy for diabetes","volume":"9","author":"Kondo","year":"2018","journal-title":"J Diabetes Investig"},{"key":"key20200713231432_b34-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1161\/CIRCRESAHA.117.311080","article-title":"Induced pluripotent stem cells 10 years later: For cardiac applications","volume":"120","author":"Yoshida","year":"2017","journal-title":"Circ Res"},{"key":"key20200713231432_b35-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s00109-017-1533-5","article-title":"Induced pluripotent stem cell-based modeling of neurodegenerative diseases: A focus on autophagy","volume":"95","author":"Jungverdorben","year":"2017","journal-title":"J Mol Med (Berl)"},{"key":"key20200713231432_b36-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s00439-016-1691-5","article-title":"Gene correction in patient-specific iPSCs for therapy development and disease modeling","volume":"135","author":"Jang","year":"2016","journal-title":"Hum Genet"},{"key":"key20200713231432_b37-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"4599","DOI":"10.1182\/blood-2011-02-335554","article-title":"Site-specific gene correction of a point mutation in human iPS cells derived from an adult patient with sickle cell disease","volume":"118","author":"Zou","year":"2011","journal-title":"Blood"},{"key":"key20200713231432_b38-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/nature10424","article-title":"Targeted gene correction of alpha1-antitrypsin deficiency in induced pluripotent stem cells","volume":"478","author":"Yusa","year":"2011","journal-title":"Nature"},{"key":"key20200713231432_b39-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.stemcr.2015.10.002","article-title":"Generation of a high number of healthy erythroid cells from gene-edited pyruvate kinase deficiency patient-specific induced pluripotent stem cells","volume":"5","author":"Garate","year":"2015","journal-title":"Stem Cell Reports"},{"key":"key20200713231432_b40-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.jgg.2015.10.001","article-title":"The epigenetic reprogramming roadmap in generation of iPSCs from somatic cells","volume":"42","author":"Brix","year":"2015","journal-title":"J Genet Genomics"},{"key":"key20200713231432_b41-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/cr.2012.175","article-title":"Embryonic stem cell and induced pluripotent stem cell: An epigenetic perspective","volume":"23","author":"Liang","year":"2013","journal-title":"Cell Res"},{"key":"key20200713231432_b42-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13287-017-0551-0","article-title":"microRNAs: Important regulators of stem cells","volume":"8","author":"Li","year":"2017","journal-title":"Stem Cell Res Ther"},{"key":"key20200713231432_b43-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.4161\/rna.25828","article-title":"MicroRNAs in regulation of pluripotency and somatic cell reprogramming: Small molecule with big impact","volume":"10","author":"Wang","year":"2013","journal-title":"RNA Biol"},{"key":"key20200713231432_b44-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1161\/CIRCRESAHA.117.305860","article-title":"Functional analysis and transcriptomic profiling of iPSC-derived macrophages and their application in modeling mendelian disease","volume":"117","author":"Zhang","year":"2015","journal-title":"Circ Res"},{"key":"key20200713231432_b45-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1002\/stem.1969","article-title":"Production of gene-corrected adult beta globin protein in human erythrocytes differentiated from patient iPSCs after genome editing of the sickle point mutation","volume":"33","author":"Huang","year":"2015","journal-title":"Stem Cells"},{"key":"key20200713231432_b46-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13287-016-0358-4","article-title":"High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins","volume":"7","author":"Chen","year":"2016","journal-title":"Stem Cell Res Ther"},{"key":"key20200713231432_b47-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"e1003210","DOI":"10.1371\/journal.pcbi.1003210","article-title":"How microRNA and transcription factor co-regulatory networks affect osteosarcoma cell proliferation","volume":"9","author":"Poos","year":"2013","journal-title":"PLoS Comput Biol"},{"key":"key20200713231432_b48-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.kint.2016.01.012","article-title":"Podocyte injury and its consequences","volume":"89","author":"Nagata","year":"2016","journal-title":"Kidney Int"},{"key":"key20200713231432_b49-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"e0135648","DOI":"10.1371\/journal.pone.0135648","article-title":"The accumulation of VEGFA in the glomerular basement membrane and its relationship with podocyte injury and proteinuria in alport syndrome","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS One"},{"key":"key20200713231432_b50-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1056\/NEJMra022296","article-title":"Alport's syndrome, goodpasture's syndrome, and type IV collagen","volume":"348","author":"Hudson","year":"2003","journal-title":"N Engl J Med"},{"key":"key20200713231432_b51-mmr-19-01-0238","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1681\/ASN.V10112446","article-title":"Anti-glomerular basement membrane disease","volume":"10","author":"Kluth","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"key20200713231432_b52-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1093\/ndt\/gfl759","article-title":"Association between the metabolic syndrome and chronic kidney disease in chinese adults","volume":"22","author":"Chen","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"key20200713231432_b53-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1097\/01.mnh.0000232875.27846.7e","article-title":"The metabolic syndrome and chronic kidney disease","volume":"15","author":"Peralta","year":"2006","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"key20200713231432_b54-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"F120","DOI":"10.1152\/ajprenal.00456.2015","article-title":"Albumin contributes to kidney disease progression in Alport syndrome","volume":"311","author":"Jarad","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"key20200713231432_b55-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/ki.2011.407","article-title":"Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy","volume":"81","author":"Gross","year":"2012","journal-title":"Kidney Int"},{"key":"key20200713231432_b56-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1681\/ASN.2005010106","article-title":"Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults","volume":"16","author":"Kurella","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"key20200713231432_b57-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1056\/NEJM199403313301301","article-title":"The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of diet in renal disease study group","volume":"330","author":"Klahr","year":"1994","journal-title":"N Engl J Med"},{"key":"key20200713231432_b58-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0092-8674(00)81279-9","article-title":"Cell adhesion: The molecular basis of tissue architecture and morphogenesis","volume":"84","author":"Gumbiner","year":"1996","journal-title":"Cell"},{"key":"key20200713231432_b59-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1101\/gad.1486806","article-title":"Cadherins in development: Cell adhesion, sorting, and tissue morphogenesis","volume":"20","author":"Halbleib","year":"2006","journal-title":"Genes Dev"},{"key":"key20200713231432_b60-mmr-19-01-0238","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1242\/dev.102.4.749","article-title":"Neural cell adhesion molecules during embryonic induction and development of the kidney","volume":"102","author":"Klein","year":"1988","journal-title":"Development"},{"key":"key20200713231432_b61-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1126\/science.1064921","article-title":"Identification of novel genes coding for small expressed RNAs","volume":"294","author":"Lagos-Quintana","year":"2001","journal-title":"Science"},{"key":"key20200713231432_b62-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature02871","article-title":"The functions of animal microRNAs","volume":"431","author":"Ambros","year":"2004","journal-title":"Nature"},{"key":"key20200713231432_b63-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.bbrc.2006.11.080","article-title":"MicroRNAs preferentially target the genes with high transcriptional regulation complexity","volume":"352","author":"Cui","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"key20200713231432_b64-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1016\/j.febslet.2008.03.004","article-title":"RNA-binding proteins and post-transcriptional gene regulation","volume":"582","author":"Glisovic","year":"2008","journal-title":"FEBS Lett"},{"key":"key20200713231432_b65-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"D92","DOI":"10.1093\/nar\/gkt1248","article-title":"starBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data","volume":"42","author":"Li","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"key20200713231432_b66-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/nrm4032","article-title":"Specificity and nonspecificity in RNA-protein interactions","volume":"16","author":"Jankowsky","year":"2015","journal-title":"Nat Rev Mol Cell Biol"},{"key":"key20200713231432_b67-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nbt.2880","article-title":"Quantitative analysis of RNA-protein interactions on a massively parallel array reveals biophysical and evolutionary landscapes","volume":"32","author":"Buenrostro","year":"2014","journal-title":"Nat Biotechnol"},{"key":"key20200713231432_b68-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1002\/bies.201500033","article-title":"Deciphering the protein-RNA recognition code: Combining large-scale quantitative methods with structural biology","volume":"37","author":"Hennig","year":"2015","journal-title":"Bioessays"},{"key":"key20200713231432_b69-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12943-017-0585-z","article-title":"miR-4775 promotes colorectal cancer invasion and metastasis via the Smad7\/TGF\u03b2-mediated epithelial to mesenchymal transition","volume":"16","author":"Zhao","year":"2017","journal-title":"Mol Cancer"},{"key":"key20200713231432_b70-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ejca.2010.11.005","article-title":"MicroRNA regulation of core apoptosis pathways in cancer","volume":"47","author":"Lima","year":"2011","journal-title":"Eur J Cancer"},{"key":"key20200713231432_b71-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/j.1365-2184.2012.00845.x","article-title":"Programmed cell death pathways in cancer: A review of apoptosis, autophagy and programmed necrosis","volume":"45","author":"Ouyang","year":"2012","journal-title":"Cell Prolif"},{"key":"key20200713231432_b72-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1677\/erc.0.0080011","article-title":"The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification","volume":"8","author":"Prenzel","year":"2001","journal-title":"Endocr Relat Cancer"},{"key":"key20200713231432_b73-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/nm1275","article-title":"Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: A new therapeutic approach","volume":"11","author":"Lautrette","year":"2005","journal-title":"Nat Med"},{"key":"key20200713231432_b74-mmr-19-01-0238","first-page":"927","article-title":"Angiotensin and EGF receptor cross-talk in chronic kidney diseases: Towards a new therapeutic approach","volume":"190","author":"Friedlander","year":"2006","journal-title":"Bull Acad Natl Med"},{"key":"key20200713231432_b75-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"7812","DOI":"10.1158\/1078-0432.CCR-04-0310","article-title":"A phase II trial of gefitinib (Iressa, ZD1839) in stage IV and recurrent renal cell carcinoma","volume":"10","author":"Dawson","year":"2004","journal-title":"Clin Cancer Res"},{"key":"key20200713231432_b76-mmr-19-01-0238","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1093\/carcin\/bgq052","article-title":"Role of the RNA-binding protein HuR in human renal cell carcinoma","volume":"31","author":"Danilin","year":"2010","journal-title":"Carcinogenesis"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"deposited":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T14:18:20Z","timestamp":1662473900000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mmr.2018.9672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,20]]},"references-count":76,"URL":"https:\/\/doi.org\/10.3892\/mmr.2018.9672","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,20]]}}}